Amaglin Tablet 2 mg (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Nokshira Co., Ltd.
MFDS item code 200403351 · Notified 2004.04.13 · Insurance code 643601260
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct treatment together with dietary and exercise therapy to improve blood sugar control for patients with type 2 diabetes. It can be used alone, but if blood sugar control is insufficient, it can be administered in combination with insulin or other hypoglycemic agents. Particularly, when blood sugar control is difficult with sulfonylureas or metformin alone, this medication can be given with metformin to enhance effectiveness. Thus, it supports various methods for blood sugar management, assisting in the treatment of diabetes.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received medication, initiate treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses greater than 4 mg; however, some patients achieved better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the patient's need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, changes in lifestyle, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no precise dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is preferable to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly; regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly controlled by immediately consuming sugar. Hypoglycemia may recur after treatment with a sulfonylurea, even when it was initially managed successfully. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure; use combination therapy with insulin when fasting blood glucose (FBG) is greater than 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and initiate insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dose adjustment is required periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical data are available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered concomitantly with metformin, and the risk may increase. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a state of coma. It should also not be administered to patients who are allergic to this medication or its ingredients, or who have severe liver or kidney dysfunction. Use in pregnant or potentially pregnant women and breastfeeding women is not recommended. Patients with severe infections, those undergoing surgery, or those who have suffered severe trauma are advised to switch to insulin treatment. Caution is advised for patients with gastrointestinal disorders due to the risk of hypoglycemia. This medication should not be administered to patients with lactose intolerance or specific genetic metabolic disorders. In the initial stages of treatment, the risk of hypoglycemia is high, so careful blood sugar monitoring is particularly necessary for elderly patients, those with poor nutritional status, and those with irregular meals. Caution is also needed for alcohol consumers or patients with kidney and liver dysfunction, as well as those with specific endocrine disorders due to a higher risk of hypoglycemia. Patients with allergies to specific dye components should also be cautious when taking this medication. Symptoms of hypoglycemia can include headache, severe hunger, nausea, fatigue, confusion, decreased consciousness, etc., and immediate treatment should be sought if such symptoms occur. Some patients may experience blurred vision, gastrointestinal symptoms, abnormal liver function, reduced blood cell counts, and allergic reactions, and should notify healthcare professionals if abnormal symptoms appear. This medication should be used together with a regular diet and exercise therapy, and in the case of hypoglycemia, sugar should be consumed to respond quickly. It may interact with other medications, so if any medications are being taken, it is essential to inform healthcare professionals. During pregnancy or breastfeeding, it is advisable to avoid using this medication, and if necessary, to switch to insulin treatment. Its safety and efficacy in pediatric patients under 18 years of age have not been established, so its use is not recommended. For elderly patients, dosage adjustments may be necessary considering reduced kidney function. In case of overdose, severe hypoglycemia may occur, and immediate emergency treatment should be sought; this medication should be kept out of reach of children.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremors, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep venous thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, biliary secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, neutropenia, agranulocytosis, pancytopenia, allergies, itching, hives, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius at room temperature. This will help maintain the effectiveness and safety of the medication for a long time.
Green oblong tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Glimepiride 2mg
Tablet · Prescription medication
Nokshira Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.